Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 28, 2014; 20(40): 14805-14820
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14805
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14805
Absolute exclusion criteria[32,104,124] |
Failed to provide informed consent |
Systematic and local microbial infections (e.g., pathogenic bacteria, virus, ova and parasites) |
Current communicable diseases |
Malignancy and chemotherapeutics administration |
Chronic gastrointestinal disorders |
Peptic ulcer diseases |
Gastroesophageal reflux disease |
GI polyposis |
Inflammatory bowel disease |
Irritable bowel syndrome |
Chronic constipation |
Traveler’s diarrhea |
Current GI symptoms |
Antibiotics administration |
Immunosuppressive agents and biological agents |
Other medications impact on the gut microbiota (e.g., proton pump inhibitor, prokinetic agents, steroids, aspirin, probiotics, etc.) |
High-risk lifestyles (e.g., intravenous drug abuse, risk sexual behaviors, etc.) |
Relative exclusion criteria[32,104,124] |
Age < 18 and > 70 yr |
History of major GI surgery |
Metabolic syndrome |
Diabetes mellitus |
Abnormal body mass index (< or > 18-25 kg/m2) |
Systemic autoimmune disease |
Atopic diseases(e.g., asthma and eczema) |
Chronic pain syndromes (e.g., chronic fatigue syndrome and fibromyalgia) |
Neuropsychiatric diseases |
- Citation: Wang ZK, Yang YS, Chen Y, Yuan J, Sun G, Peng LH. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. World J Gastroenterol 2014; 20(40): 14805-14820
- URL: https://www.wjgnet.com/1007-9327/full/v20/i40/14805.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i40.14805